INTEGRATED BIOPHARMA INC
For the period ended Jun 30, 2026. Filed Sep 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 25, 2026
INBPStored price and day change unavailable
What changed in Management’s Discussion and Analysis?
Read the current filingComparison unavailable
We could not identify this Item in the current filing’s readable text.
Earlier comparable report: 10-K, period ended 2025-06-30, filed 2025-09-23. Read that report
Unavailable is not the same as unchanged.